Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/7336| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ilievska Poposka, Biljana | en_US |
| dc.contributor.author | Smichkoska, Snezhana | en_US |
| dc.contributor.author | Crvenkova, Simonida | en_US |
| dc.contributor.author | Zafirovska Ivanovska, B | en_US |
| dc.contributor.author | Stefanovski, T | en_US |
| dc.contributor.author | Petrusevska, G | en_US |
| dc.date.accessioned | 2020-03-19T09:04:43Z | - |
| dc.date.available | 2020-03-19T09:04:43Z | - |
| dc.date.issued | 2008-12 | - |
| dc.identifier.issn | 0351-3254 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/7336 | - |
| dc.description.abstract | The expression of Bcl-2 oncoprotein is associated with inhibition of apoptosis and prolonged cell survival. The purpose of this study was to investigate Bcl-2 protein expression in patients with small-cell lung cancer (SCLC) in order to see if it was related to clinicopathological features and to prognosis. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Macedonian Academy of Sciences and Arts | en_US |
| dc.relation.ispartof | Prilozi | en_US |
| dc.title | Bcl-2 as a prognostic factor for survival in small-cell lung cancer | en_US |
| dc.type | Article | en_US |
| dc.identifier.volume | 29 | - |
| dc.identifier.issue | 2 | - |
| item.fulltext | No Fulltext | - |
| item.grantfulltext | none | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.